Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 25, 2018 11:11 ET | Source: BioCorRx Inc

BioCorRx CEO Brady Granier Discusses BioCorRx Recovery Program on This Life #YouLive Podcast Hosted by Dr. Drew

ANAHEIM, CA, Sept. 25, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE-- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid...
September 24, 2018 08:00 ET | Source: Acasti Pharma, Inc.

Acasti Pharma Appoints Jean-François Boily as Vice President of Finance

LAVAL, Québec, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST) (the “Company” or “Acasti”), a biopharmaceutical innovator focused on the research, development...
September 20, 2018 09:24 ET | Source: BioCorRx Inc

BioCorRx to Exhibit at the 2nd Annual National Opioid Crisis Management Congress

ANAHEIM, CA, Sept. 20, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of alcohol and opioid...
September 20, 2018 08:00 ET | Source: Avalon GloboCare Corp.

Avalon GloboCare Commences Operation of its Core GMP Platform, Epicon Biotech, to Facilitate Clinical Development of Cellular Therapies

FREEHOLD, N.J., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that the Company has officially...
September 20, 2018 08:00 ET | Source: MYnd Analytics, Inc.

MYnd Analytics to Provide TeleEAP Services for Integrated Behavioral Health, a National Managed Behavioral Health Company

MISSION VIEJO, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...
September 18, 2018 08:52 ET | Source: Acasti Pharma, Inc.

Acasti Pharma Provides Clinical and Market Update

TRILOGY phase 3 studies exceed 75% enrollment; on track to report topline results in 2019 LAVAL, Quebec, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a...
September 18, 2018 07:30 ET | Source: Adial Pharmaceutical, Inc.

Addiction Drug Developer Adial Pharmaceuticals Successfully Passes Patent Opposition Period in Europe for AD04 in Alcohol Use Disorder; Reports No Challenges to European Patent

Patent portfolio significantly enhanced and extended by this patent CHARLOTTESVILLE, Va., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage...
September 17, 2018 12:58 ET | Source: MYnd Analytics, Inc.

MYnd Analytics Announces Nationwide Expansion of Telepsychiatry & Telebehavioral Health Services for Leading EAP Provider Claremont Behavioral Services

MISSION VIEJO, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...
September 17, 2018 08:43 ET | Source: MYnd Analytics, Inc.

FDA Designates Breakthrough Device Status for MYnd Analytics’ PEER 4.0

MISSION VIEJO, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...
September 14, 2018 12:09 ET | Source: Influenster, Inc.

Influenster 2018 “Reviewers’ Choice Awards: Best In Beauty” Winners Revealed

NEW YORK, Sept. 14, 2018 (GLOBE NEWSWIRE) -- Influenster, the leading platform where millions of consumers research and review products, and where brands can connect with these highly-engaged and...